About NeuroDx
NeuroDx is a company based in Bensalem (United States) founded in 2008 by Frederick J Fritz. NeuroDx offers products and services including ShuntCheck III Test and ShuntCheck Training Video. NeuroDx operates in a competitive market with competitors including CereVasc, IRRAS, Tissuemed, Longeviti and Aqueduct Critical Care, among others.
- Headquarter Bensalem, United States
- Founders Frederick J Fritz
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1 M (USD), Grant
Apr 01, 2013
-
Investors
HHS
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroDx
NeuroDx offers a comprehensive portfolio of products and services, including ShuntCheck III Test and ShuntCheck Training Video.
Non-invasive test to detect CSF flow and obstructions.
Video guide for conducting CSF shunt flow tests.
Funding Insights of NeuroDx
Investors in NeuroDx
NeuroDx has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, National Institute of Neurological Disorders and Stroke and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research on neurological disorders and stroke is conducted and funded.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for NeuroDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroDx
Investment portfolio details for NeuroDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroDx
Detailed financials for NeuroDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurodx Comparisons
Peer comparison for NeuroDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroDx
NeuroDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CereVasc, IRRAS, Tissuemed, Longeviti and Aqueduct Critical Care, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
eShunt device is developed for communicating hydrocephalus treatment.
|
|
| Locked | Locked | Locked |
Provider of devices for fluid control and management after surgery
|
|
| Locked | Locked | Locked |
Bioadhesive films are developed to seal leaks in surgical procedures.
|
|
| Locked | Locked | Locked |
Implantable neurosurgical devices are developed for cranial defect correction.
|
|
| Locked | Locked | Locked |
Novel products to manage Cerebral Spinal Fluid (CSF) pressure
|
Detailed competitors of NeuroDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurodx
Complete news archive for NeuroDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroDx
NeuroDx was founded in 2008.
NeuroDx is headquartered in Bensalem, United States. It is registered at Bensalem, Pennsylvania, United States.
Frederick J Fritz is the current CEO of NeuroDx. They have also founded this company.
NeuroDx Development is a medical device company which is developing products for the neurosurgical market. The Company has developed two products for assessing shunt function in hydrocephalus patients: ShuntCheck-Micro-Pumpe, eight-minute test of cerebrospinal fluid (CSF) shunt flow, and Continuous Real Time (CRT) ShuntCheck, which uses thermal dilution to monitor changes in shunt flow over longer time periods. The companys follow-on products, an implantable intracranial pressure monitoring device and a non-invasive monitor of intracranial pressure, are in proof of concept development.
NeuroDx's top competitors include CereVasc, Tissuemed and Aqueduct Critical Care.
NeuroDx offers ShuntCheck III Test and ShuntCheck Training Video.
NeuroDx has 3 investors. Key investors include HHS, National Institute of Neurological Disorders and Stroke, and National Science Foundation.